Wegovy vs Mounjaro: Complete Dosing & Mechanism Guide
Understanding 5mg Mounjaro Equivalent to Wegovy Dosing
The 5mg Mounjaro equivalent to Wegovy comparison requires understanding fundamentally different dose escalation schedules. Mounjaro (tirzepatide) starts at 2.5mg weekly, progressing through 5mg, 7.5mg, 10mg, 12.5mg, up to 15mg maintenance doses over 20+ weeks. Wegovy (semaglutide) follows a different pathway: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), reaching 2.4mg maintenance by week 17. Neither treatment allows dose-skipping, as gradual escalation minimises gastrointestinal side effects whilst optimising therapeutic response.
When patients ask about 5mg Mounjaro equivalent to Wegovy, they're typically seeking comparable efficacy stages rather than direct dose conversion. Mounjaro's 5mg represents an early therapeutic dose (weeks 5-8), whilst Wegovy's equivalent therapeutic progression occurs around the 1mg stage (weeks 9-12). Both are prescription-only medicines requiring clinical assessment, and your prescriber will determine appropriate starting doses based on individual medical history, current medications, and weight management goals.
Pricing Comparison: 5mg Mounjaro Equivalent to Wegovy Costs
EverydayMeds provides transparent pricing for both Wegovy and Mounjaro, allowing direct cost comparison. Wegovy single pens cost £79.99 (0.25mg starter), £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 (2.4mg maintenance). Our Intro Trio bundle (0.25mg, 0.5mg, 1mg) costs £299.99, covering your first 12 weeks. New customers apply code FIRST40 at checkout, whilst returning customers use DOSE25 to access these competitive prices.
Mounjaro pricing follows its own structure, reflecting the different active ingredient (tirzepatide vs semaglutide) and manufacturing processes. Both treatments require ongoing prescription renewals every 3-6 months, making bundle options particularly valuable for maintaining consistent supply. Our 2-pen and 3-pen bundles provide convenience benefits including Confirmed Availability, reduced delivery frequency, and streamlined reordering processes, rather than simple cost savings.
Clinical Evidence: 5mg Mounjaro Equivalent to Wegovy Efficacy
Wegovy's clinical evidence comes primarily from the STEP trial programme, with STEP 1 demonstrating approximately 15% average weight loss at 68 weeks versus 2.4% with placebo (Wilding et al., NEJM, 2021). STEP 5 showed sustained clinically studied weight loss at 2 years, whilst SELECT trial data revealed 20% reduction in major cardiovascular events. These results occurred alongside reduced-calorie diet and increased physical activity in adults with BMI ≥30 or ≥27 with weight-related comorbidities.
Mounjaro's SURPASS trials focused on diabetes management, with SURMOUNT studies examining weight management applications. Both treatments demonstrated efficacy in clinical settings, though direct comparison isn't appropriate due to different trial designs, participant populations, and study endpoints. Your prescriber will consider individual medical history, comorbidities, and treatment goals when discussing which option may be most suitable for your circumstances.
How Wegovy Works: GLP-1 Mechanism for Weight Management
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormone responsible for post-meal satiety signals. When administered weekly via the FlexTouch pen, semaglutide binds to GLP-1 receptors in your brain's appetite control centres, potentially reducing hunger and promoting feelings of fullness after smaller meals. This mechanism may help reduce food cravings and support portion control when combined with lifestyle modifications. The treatment also slows gastric emptying, extending the duration of meal satisfaction and supporting adherence to reduced-calorie eating plans. Clinical studies suggest these effects work synergistically with diet and exercise to support sustainable weight management outcomes.
Ordering Process: 5mg Mounjaro Equivalent to Wegovy Assessment
EverydayMeds streamlines access to both Wegovy and Mounjaro through our comprehensive online clinical assessment taking approximately 3 minutes to complete. You'll provide detailed medical history, current medications, previous weight management attempts, and specific treatment preferences including any 5mg Mounjaro equivalent to Wegovy dosing questions. Our UK-registered prescribers (GPhC #9012878) review submissions within 3 working days as standard, or 24 hours via express service. Once approved, both treatments ship via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. Your package includes detailed administration guidance, dose escalation schedules, and direct access to our clinical team for ongoing support throughout your treatment journey.
Storage and Practical Considerations: Wegovy vs Mounjaro
Wegovy offers significant practical advantages for patients requiring travel flexibility or irregular refrigeration access. Unopened pens store in standard household fridges at 2-8°C, but once removed, remain stable at room temperature below 30°C for up to 6 weeks. This compares favourably to Mounjaro's 21-day room temperature limit, making Wegovy particularly suitable for frequent travellers or those with inconsistent refrigeration. Both treatments use pre-filled pen devices, though Wegovy's FlexTouch system features dose confirmation windows and ergonomic design elements. Weekly injection timing remains consistent for both, though your prescriber may recommend different injection sites or rotation patterns based on individual tolerance and absorption characteristics.
Dual Mechanism vs Single Target: Why 5mg Mounjaro Equivalent to Wegovy Matters
The fundamental difference between 5mg Mounjaro equivalent to Wegovy lies in their receptor targeting mechanisms rather than simple dose conversion. Mounjaro (tirzepatide) activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors, creating dual incretin effects on appetite, glucose regulation, and gastric emptying. This dual agonism may offer different metabolic benefits compared to Wegovy's selective GLP-1 targeting, though individual responses vary significantly between patients.
Your prescriber will consider factors beyond simple 5mg Mounjaro equivalent to Wegovy dose matching when selecting appropriate treatment. Medical history including diabetes status, cardiovascular risk factors, previous medication responses, and lifestyle factors all influence treatment selection. Both remain prescription-only medicines requiring ongoing medical supervision, regular monitoring, and integration with comprehensive lifestyle modification programmes for optimal outcomes.
Choose Your Treatment: Both Available from EverydayMeds
EverydayMeds provides unique access to both Wegovy and Mounjaro, eliminating the need to search multiple providers when exploring your 5mg Mounjaro equivalent to Wegovy options. Our clinical team can facilitate treatment switches if initial selection proves unsuitable, whilst maintaining consistent prescription records and progress monitoring. New customers access competitive pricing with code FIRST40, whilst returning customers use DOSE25 for continued savings. Start your clinical assessment today at https://everydaymeds.co.uk/collections/weight-loss to discuss which prescription-only weight management treatment aligns with your medical needs and lifestyle requirements. Both treatments require commitment to reduced-calorie diet and increased physical activity for optimal results, supported by our comprehensive patient guidance resources.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
